Skip to main content
Premium Trial:

Request an Annual Quote

Progknowse, Premier Join With Three Health Systems on Predictive Analytics

NEW YORK – Progknowse, a developer of predictive analytics to support precision medicine, today announced partnerships with three East Coast health systems. Also participating is healthcare group purchasing alliance and services company Premier.

LifeBridge Health in Baltimore, Riverside Health System in Newport News, Virginia, and St. Luke's University Health Network in Bethlehem, Pennsylvania, have signed on to use the under-development Progknowse technology platform. McLean, Virginia-based Progknowse is creating technology to make actionable therapeutic recommendations to clinicians.

The company said that the technology will be compatible with Premier's PremierConnect performance improvement system. PremierConnect contains de-identified clinical outcomes data from about 45 percent of all patient discharges in the US, according to Charlotte, North Carolina-based Premier.

To power its predictive analytics, Progknowse is working with sequencing companies and health systems to build a clinical and genomic dataset. The startup did not provide a timetable for creating this dataset.

"Our partnership with Premier and these exemplary health systems enables clinician-driven data science collaboration that helps solve the problems of predictive accuracy and risk-adjustment crucial to improving the way care is delivered in precise and personalized ways," Progknowse Founder and CEO Marshall Ruffin said in a statement.

"We enjoy working with other like-minded regional health systems to build a platform for precision medicine that is both innovative and affordable," added Riverside Health System Chief Medical Informatics Officer Charles Frazier. "By applying these predictive algorithms to our health data, we hope to accurately predict patients' outcomes of a specific treatment to help patients, their families, and their clinicians select best treatments for them."

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.